Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Sodium measurement, urine |
Component |
False |
Sodium electrolyte |
Inferred relationship |
Some |
2 |
24 hour urine sodium output measurement |
Component |
False |
Sodium electrolyte |
Inferred relationship |
Some |
3 |
fysiologisk saltvand |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 % nebulisatorampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Sodium chloride 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid tablet 600 mg med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Product containing sodium chloride in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Sodium lactate-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Sodium chloride 9 mg/mL solution for ocular irrigation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Sodium chloride 50 mg/g eye ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Product containing precisely sodium chloride 9 milligram/1 milliliter conventional release nasal drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Product containing precisely sodium chloride 9 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 % steril spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid skyllevæske til øjne |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,225 %/glucose 5 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 % øjendråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 5 % øjendråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
kombinationspræparat med natriumlactat i halv styrke/glucose 5 %, infusionsvæske, opløsning i pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Ringer-laktat, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
kombinationspræparat med natriumlactat i halv styrke, infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Darrows infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
kaliumchlorid 10 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
kaliumchlorid 10 mmol/glucose 5 %/natriumchlorid 0,45 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
kaliumchlorid 13,5 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
kaliumchlorid 20 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
kaliumchlorid 20 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
kaliumchlorid 27 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
kaliumchlorid 40 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
kaliumchlorid 10 mmol/natriumchlorid 0,9 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
kaliumchlorid 13,5 mmol/natriumchlorid 0,9 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
kaliumchlorid 20 mmol/natriumchlorid 0,9 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
kaliumchlorid 27 mmol + natriumchlorid 0,9 % infusionsvæske, opløsning i pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
kaliumchlorid 20 mmol/natriumklorid 0,9 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
kaliumchlorid 40 mmol/natriumchlorid 0,9 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Ringers infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,45 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,18 %/glucose 4 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,18 %/glucose 10 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,45 %/glucose 2,5 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,45 % + glucose 5 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumklorid 0,9 %/glucose 5 % infusionsvæske opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 % steril irrigationsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchloridforbindelse 1,5 % mundskyllevand |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 % øjendråber til engangsbrug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 % væske i pose til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
kalium i saltvand til infusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
kalium + glucose/saltvand infusionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumprodukt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Sodium chloride-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Product containing glucose and sodium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 % injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Product containing sodium in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Sodium chloride 9 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumlactat 0,16 molær infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
kaliumchlorid 10 %/natriumchloridd 0,45 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
koffein og natriumbenzoat injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Ringers opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchloridopløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
hypertont saltvand |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Product containing sodium lactate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Product containing sodium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Product containing sodium benzoate and sodium phenylacetate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Sodium benzoate 100 mg/mL and sodium phenylacetate 100 mg/mL solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Saline for nebulization |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Oral form sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Sodium chloride 9mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Sodium chloride 2.25g solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
ioxaglatmeglumin + natrium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
fysiologisk saltvand + kaliumchlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Ringer-laktat, opløsning + glucose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Ringer-laktat, opløsning med 2,5 % glucose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Ringers opløsning med lactat + 5 % glucose + 0,15 % kaliumhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Sodium chloride [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Sodium chloride [nose] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Sodium chloride [mouth] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Sodium chloride [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
kaliumchlorid 10 % + natriumchlorid 0,45 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
kombinationspræparat med natriumlactat infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
kombinationspræparat med natriumlactat infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
kombinationspræparat med natriumlactat, infusionsvæske, opløsning, polyethylenflaske a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumlactat Komb., infusionsvæske, opløsning i polyethylenflaske a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Darrows infusionsvæske, opløsning, pose á 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Darrows infusionvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Ringers infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Ringers infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
Ringers infusionsvæske, opløsning, polyætylenflaske a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 % infusionsvæske, opløsning, pose a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 % infusionsvæske, opløsning, pose a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 % infusionsvæske, opløsning, pose a 150 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 % infusionsvæske, opløsning, pose a 250 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,18 %/glucose 4 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,18 %/glucose 4 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,18 %/glucose 4 % infusionsvæske, opløsning, polyætylenflaske a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 %/glucose 5 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 %/glucose 5 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 %/glucose 5 % infusionsvæske, opløsning, polyætylenflaske a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 % injektionsvæske, opløsning, ampul a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|
natriumchlorid 0,9 % injektionsvæske, opløsning, ampul a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium electrolyte |
Inferred relationship |
Some |
|